Now I have enough perspective. Let me compile the final review.

**Calibration Summary**:

| Anchor | Path | Avg Score | Round | Comparison |
|---|---|---|---|---|
| LanGoal (LLM RL exploration) | hCfhfwSfCg | 2.00 | R1 | Much weaker — unrelated domain, weak contribution |
| D2Coder | dsALpkd1OU | 1.67 | R1 | Much weaker — different domain |
| Time series SPF clustering | w5h443GIGo | 2.33 | R1 | Weaker — niche contribution |
| LLM biomedical KG | K1bv86Uvbp | 3.00 | R1 | Weaker — less novel |
| scMPT (LLM + sc-foundation) | nUpM7egYFd | 3.40 | R2 | Weaker — more incremental contribution |
| LLM4GRN (LLM for GRN) | jLd7OyAD4Y | 4.33 | R1/R2 | Comparable — similar validation issues, 3 datasets vs 1 |
| ZerOmics (LLM zero-shot sc) | J1xtkJmFY3 | 4.67 | R2 | Slightly stronger empirically (9 datasets, 3 tasks) |
| Geometric modularity clustering | KiK4MNkuiQ | 5.00 | R1 | Stronger — more thorough evaluation |
| Single-cell retrieval benchmark | iOltCu4TPS | 5.00 | R2 | Stronger — comprehensive benchmark |
| BioDiscoveryAgent | HAwZGLcye3 | 6.40 | R1 | Much stronger — 6 datasets, proper baselines, accepted |
| LLM equation discovery | m2nmp8P5in | 8.00 | R1 | Much stronger — completely different tier |

**Bracket**: Initially 3.5–5.5. Round 2 narrowed to 3.5–5.0, with closest comparables being LLM4GRN (4.33) and ZerOmics (4.67). The paper is weaker than ZerOmics in empirical scope but more honest in claims; comparable to LLM4GRN in overall quality. Adjusting downward per overestimation guidance: **final score 4.0**.

---

## Summary
HypoGeneAgent proposes an LLM-based framework for cluster resolution selection in single-cell/Perturb-seq data. An LLM (GPT-o3) annotates each cluster's gene signature with ranked GO hypotheses; these are embedded and compared via cosine similarity to produce intra-cluster agreement (ICS) and inter-cluster distinctiveness (ICD), which are combined into a Resolution Score. The resolution maximizing this score is selected. The method is demonstrated on one K562 CRISPRi Perturb-seq dataset, with Stage 1 benchmarking on 100 GOBP gene sets to select model/prompt/embedding configurations.

## Strengths
- **Novel formulation of resolution selection as annotation-consistency optimization**: The paper identifies a genuine gap — statistical clustering metrics (silhouette, modularity) ignore biological interpretability — and proposes a principled quantitative framework (ICS + ICD → Resolution Score) to close it. The formal definitions in Section 3.4 are clear and well-motivated.
- **Systematic Stage 1 benchmarking of LLM configurations**: Before deployment on Perturb-seq data, the paper ablates multiple LLM backbones (GPT-4o, GPT-o3, GPT-5, Gemini-2.0-flash, Gemini-2.5-pro), three embedding methods, two prompt designs, and temperature sweeps on 100 GOBP gene sets (Section 4.2-4.3). This empirically justifies the GPT-o3 + hypothesis prompt configuration carried into Stage 2.
- **Dual-level application on the same dataset**: The method is applied independently at both gene-expression cluster level (Figure 3) and perturbation cluster level (Figure 4), producing clear optima (r=0.4 GEX, r=0.5 perturbation) with converging ICS/ICD components.
- **Internal consistency of ICS/ICD decomposition**: The individual ICS and ICD box plots (Figures 3c-d, 4c-d) independently corroborate the combined Resolution Score optimum — the same resolution that maximizes RS also shows low inter-cluster similarity and high intra-cluster similarity.

## Weaknesses

### Fatal
None.

### Major
- **No external validation that the chosen resolution is biologically superior to alternatives**: The core claim is that the Resolution Score selects more biologically meaningful clustering granularities than silhouette, modularity, or enrichment analysis. The paper shows that different methods pick different resolutions (RS: r=0.4; silhouette: r=0.5–0.6; modularity: r=0.7) but never adjudicates which is correct via an independent criterion. The UMAP at r=0.4 "looks clean," but UMAPs can look clean at many resolutions. Section 4.4.3 applies a variant of the same ICS/ICD framework to enrichment analysis terms (Figure 6), but this is largely circular — it validates an LLM-consistency score with a similar semantic-consistency score. Moreover, Figure 6a actually shows the enrichment-based score peaking at r=0.7, not r=0.4 or r=0.5; the paper then adjusts via "consider the reasonability of cluster numbers we expected" to claim consistency. The abstract's claim that the method "establish[es] LLM agents as objective adjudicators of cluster resolution" is not supported by the evidence presented.

- **Only one dataset evaluated for the main claim**: The entire resolution-selection evaluation (Stage 2) uses a single K562 CRISPRi Perturb-seq dataset. The paper frames HypoGeneAgent as a "general-purpose tool" for "single-cell, perturb-seq and multi-omics analyses" (Section 5), yet its empirical basis is one cell line, one perturbation type, one experimental context. While the paper acknowledges this as a limitation, the single-dataset evaluation is insufficient to support claims of generality.

- **ICS measures LLM output consistency, not necessarily biological coherence**: ICS is defined as the cosine similarity among the LLM's own hypotheses about a cluster (Section 3.4). The paper treats high ICS as evidence that the cluster is "internally coherent and biologically robust," but the metric fundamentally measures the LLM's output distribution. A cluster could receive high ICS because the LLM generates semantically similar descriptions regardless of whether the underlying gene set is genuinely coherent, and conversely a biologically coherent cluster might receive low ICS if the LLM uses diverse phrasing. Since the entire Resolution Score pipeline uses only LLM outputs (no ground truth in the loop), it functions as a self-consistency check on the LLM rather than an independently validated measure of cluster quality.

### Minor
- **The weighting parameter w = 1/3 lacks robust justification**: The paper states that w = 1/3 was "chosen by a small grid search and found to give a stable ordering of resolutions across data sets" (Section 3.4), but "across data sets" cannot refer to the main evaluation (only one dataset). The sensitivity analysis is deferred to Figure S5, but the main text reports only that "for different clusters, the tendency of resolution score changing with w can be different." It is unclear whether changing w shifts the optimal resolution, which is critical for a method claiming to make resolution selection "objective."

- **Gene signature construction is under-specified**: The paper states that signatures consist of "the most over-expressed genes ranked by log-fold-change" (Section 3.3) but does not specify how many genes are included, whether fold-change or expression thresholds are applied, or how these choices vary across resolutions. The gene-to-cluster assignment matrix is noted as 3000 × 10 (Section 3.2) without explanation. If signature composition varies systematically with resolution, this could drive the Resolution Score independently of biological cluster quality.

- **MultiK, a directly relevant baseline, is not compared against**: MultiK (Liu et al. 2021) is discussed in related work as a tool for "objective selection of insightful Ks" in scRNA-seq data, but it is never used as a baseline in the resolution-selection comparison. The paper compares only against silhouette, modularity, and enrichment analysis.

### Trivial
None.

## Nice-to-Haves
- Quantify computational cost (tokens, time, dollar amount) of LLM API calls across the resolution grid.
- Report variance of the Resolution Score under repeated LLM calls with the same input to assess signal-to-noise ratio.
- Include a simpler baseline that applies the same ICS/ICD logic to GO enrichment terms directly and compare head-to-head with the LLM-based approach, rather than presenting the enrichment analysis as post-hoc validation.

## Removed Points
These points are flagged to be removed, treat them with caution:
- **"Stage 1 contributes little to the paper's novel contribution"**: Stage 1 is a configuration/ablation study that justifies model choices. It serves a legitimate purpose even if the finding (thinking models > non-thinking) aligns with prior work. The paper is transparent about this being a parameter-selection stage.
- **"The paper lacks a clear statement of what would falsify the method's claims"**: This is a generic philosophical concern that could be raised about most empirical papers. The method's claims are evaluable through the experiments presented; the issue is the quality of those experiments, not the absence of a falsification statement.
- **"The clustering procedure is relegated to the appendix"**: The paper explicitly directs readers to the appendix for clustering details (Section 3.2). This is a standard presentation choice in ML conference papers with page limits.

## Novel Insights
None beyond the paper's own contributions. The core idea of using LLM annotation consistency as a signal for clustering resolution is genuinely novel, but the review process did not surface additional insights beyond what the paper itself proposes.

## Suggestions
- The most impactful improvement would be an external validation criterion: construct a benchmark with ground-truth perturbation labels (e.g., perturbations with known functional groupings), measure whether the selected resolution better separates perturbations with distinct mechanisms than alternatives, or have domain experts independently select resolutions and measure agreement with HypoGeneAgent.
- Decouple annotation quality from annotation consistency: on the Stage 1 GOBP benchmark where ground-truth annotations exist, compute both ICS and semantic accuracy (S_k^cos) and report whether they correlate. If ICS is high when accuracy is low, the metric is measuring LLM behavior, not biology.
- Compare against MultiK as a baseline since it is a directly relevant published method for resolution selection in scRNA-seq.

MY FINAL SCORE: <score>4.0</score>
MY FINAL DECISION: <decision>Reject</decision>